CDK9 expression and clinical breast cancer outcome. Kaplan-Meier curve indicating the correlation between CDK9 expression (high: n = 77, low: n = 77) and relapse-free survival (RFS) in breast cancer patients. Prognostic Plot created with PROGgeneV2 software using the GSE9893 dataset. The cohort was divided at median of gene expression. Log-rank (Mantel-Cox) test P = 0.01141, Hazard Ratio (HR): 1.63.
MDA-MB-231 (left panels) and MDA-MB-453 (right panels) cells (2D) or mammospheres (spheres) were lysed and subjected to SDS-PAGE. Same amounts of lysates were used for analysis and immunoblotted for antibodies against RNA Pol II pSer2, MYC, CDK9, OCT4 and HSP90. ChemiDoc MP Imaging System (BioRad) was used for visualization. TCGA breast cancer sample ID  TCGA-A1-A0SK-01  TCGA-A1-A0SO-01  TCGA-A1-A0SP-01  TCGA-A2-A04P-01  TCGA-A2-A04Q-01  TCGA-A2-A04T-01  TCGA-A2-A04U-01  TCGA-A2-A0CM- 
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